Related Experiment Video
Updated: Jun 1, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Complement C3a Receptor 1 and Complement C5a Receptor 1 Are Dual Contributors of Chronic-Plus-Binge-Induced Hepatic
Lauren N Rutt1, Shannon M Kirkpatrick1, Paige E Anton1
1Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Ethanol consumption affects liver macrophages by increasing intracellular complement components, contributing to persistent inflammation in alcohol-associated liver disease (ALD). Understanding this "complosome" offers new insights into ALD pathogenesis.
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Alcohol-associated liver disease (ALD) is a major cause of liver mortality, characterized by chronic inflammation and immune dysfunction.
- The precise mechanisms underlying immune dysfunction in ALD remain incompletely understood.
Purpose of the Study:
- To investigate the role of the intracellular complement system, termed the "complosome", in the immune dysfunction observed in ALD.
- To characterize the expression and function of anaphylatoxin receptors (C3aR1 and C5aR1) on macrophages in the context of ethanol exposure.
Main Methods:
- Analysis of liver explants from ALD patients and healthy donors.
- Utilized chronic-plus-binge ethanol feeding in mice deficient in anaphylatoxin receptors.
- Employed in vitro models using bone marrow-derived macrophages (BMDMs) stimulated with ethanol and lipopolysaccharide (LPS).
Main Results:
- Anaphylatoxin receptor expression was elevated in macrophages from ALD patients.
- Ethanol increased C3aR1 and C5aR1 expression on Kupffer cells in mice, with C5aR1 deficiency protecting against liver injury.
- Ethanol and LPS increased intracellular complement components and anaphylatoxin receptors in BMDMs, impacting NLRP3 inflammasome activation and IL-1β production.
Conclusions:
- Ethanol exposure alters macrophage intracellular complement pathways, potentially driving non-resolving inflammation in ALD.
- Targeting intracellular complement components and anaphylatoxin receptors may offer therapeutic strategies for ALD.
Related Concept Videos
Allergic Drug Reactions
Complement System
Drug Toxicity: Allergic Reactions
Chronic Inflammation: Introduction
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...